Catheter Precision, Inc. (RMED) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc. (formerly Ra Medical Systems, Inc.) filed this Current Report on Form 8-K on December 18, 2023. The filing serves to announce the Company's financial results for the three and six months ended June 30, 2023. The Company is incorporated in Delaware and its common stock trades on the NYSE American under the symbol RMED.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the press release attached as Exhibit 99.1, which is incorporated by reference but not included in the text of this 8-K.
Material Changes
The filing does not explicitly list material changes versus prior periods within the text body. It directs investors to the attached press release (Exhibit 99.1) for the full details of the results for the periods ended June 30, 2023.
Guidance, Outlook, and Risks
This 8-K filing does not contain specific management commentary, forward-looking guidance, risk factors, or contingencies. The document states that the information is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and six months ended June 30, 2023.
- Verify the Company's name change from Ra Medical Systems, Inc. to Catheter Precision, Inc.
- Confirm the trading symbol RMED on the NYSE American exchange.
- Note that the financial data in this 8-K is not considered "filed" under Section 18 of the Exchange Act.